Skip to main content
Top
Published in: Diabetologia 4/2005

01-04-2005 | Short communication

Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes

Authors: J. R. Larsen, M. Brekke, L. Bergengen, L. Sandvik, H. Arnesen, K. F. Hanssen, K. Dahl-Jorgensen

Published in: Diabetologia | Issue 4/2005

Login to get access

Abstract

Aims/hypothesis

Intima media thickness (IMT) of the common carotid artery (CCA) is a validated surrogate marker of early atherosclerosis. The aim of our study was to assess the association between IMT in CCA and long-term mean HbA1c in type 1 diabetes. We also elucidated the association between carotid IMT and preclinical coronary atherosclerosis.

Methods

In 39 individuals with type 1 diabetes, HbA1c was measured prospectively over 18 years. The IMT examinations were performed with high-resolution ultrasound. The association between carotid IMT and preclinical coronary atherosclerosis (assessed by intravascular ultrasound [IVUS]) was tested in 29 of the patients.

Results

Mean HbA1c over 18 years was 8.2% (range: 6.6–11.3%). Mean age at follow-up after 18 years was 43 years and mean duration of diabetes was 30 years. IMT was significantly higher in diabetic patients than in an age- and sex-matched reference population. The IMT values were at the same level as for controls who were 20 years older. In women, HbA1c was significantly associated with mean average CCA IMT (r 2=0.77, p<0.0001 when adjusted for age), whereas there was no significant association for men. Among women, a significant association was also found between carotid IMT and the percentage of coronary vessel area stenosis (r=0.65, p=0.03).

Conclusions/interpretation

The present findings suggest an important role of long-term hyperglycaemia in the development of atherosclerosis, especially in women with type 1 diabetes.
Type 1 diabetes patients have earlier development of, and more advanced, atherosclerosis compared with an age- and sex-matched reference population. In women, carotid IMT reflects preclinical coronary atherosclerosis.
Literature
1.
go back to reference Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH et al (1998) The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 128:262–269 Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH et al (1998) The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 128:262–269
2.
go back to reference Jensen-Urstad KJ, Reichard PG, Rosfors JS, Lindblad LE, Jensen-Urstad MT (1996) Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes 45:1253–1258 Jensen-Urstad KJ, Reichard PG, Rosfors JS, Lindblad LE, Jensen-Urstad MT (1996) Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes 45:1253–1258
3.
go back to reference Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY et al (2003) Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 348:2294–2303CrossRef Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY et al (2003) Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 348:2294–2303CrossRef
4.
go back to reference Larsen J, Brekke M, Sandvik L, Arnesen H, Hanssen KF, Dahl-Jorgensen K (2002) Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes 51:2637–2641 Larsen J, Brekke M, Sandvik L, Arnesen H, Hanssen KF, Dahl-Jorgensen K (2002) Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes 51:2637–2641
5.
go back to reference Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E et al (1986) Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J (Clin Res Ed) 293:1195–1199 Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E et al (1986) Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J (Clin Res Ed) 293:1195–1199
6.
go back to reference Stensland-Bugge E, Bonaa KH, Joakimsen O (2001) Age and sex differences in the relationship between inherited and lifestyle risk factors and subclinical carotid atherosclerosis: the Tromso study. Atherosclerosis 154(2):437–448CrossRef Stensland-Bugge E, Bonaa KH, Joakimsen O (2001) Age and sex differences in the relationship between inherited and lifestyle risk factors and subclinical carotid atherosclerosis: the Tromso study. Atherosclerosis 154(2):437–448CrossRef
7.
go back to reference Stensland-Bugge E, Bonaa KH, Joakimsen O (1997) Reproducibility of ultrasonographically determined intima-media thickness is dependent on arterial wall thickness. The Tromso study. Stroke 28:1972–1980 Stensland-Bugge E, Bonaa KH, Joakimsen O (1997) Reproducibility of ultrasonographically determined intima-media thickness is dependent on arterial wall thickness. The Tromso study. Stroke 28:1972–1980
8.
go back to reference Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC et al (1987) Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 59:750–755CrossRefPubMed Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC et al (1987) Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 59:750–755CrossRefPubMed
9.
go back to reference Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR et al (2003) Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46:760–765CrossRef Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR et al (2003) Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46:760–765CrossRef
10.
go back to reference Orchard TJ, Stevens LK, Forrest KY, Fuller JH (1998) Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe. Int J Epidemiol 27:976–983CrossRef Orchard TJ, Stevens LK, Forrest KY, Fuller JH (1998) Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe. Int J Epidemiol 27:976–983CrossRef
11.
go back to reference Pajunen P, Taskinen MR, Nieminen MS, Syvanne M (2000) Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus. Am J Cardiol 86:1080–1085CrossRef Pajunen P, Taskinen MR, Nieminen MS, Syvanne M (2000) Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus. Am J Cardiol 86:1080–1085CrossRef
12.
go back to reference Lloyd CE, Kuller LH, Ellis D, Becker DJ, Wing RR, Orchard TJ (1996) Coronary artery disease in IDDM. Gender differences in risk factors but not risk. Arterioscler Thromb Vasc Biol 16:720–726 Lloyd CE, Kuller LH, Ellis D, Becker DJ, Wing RR, Orchard TJ (1996) Coronary artery disease in IDDM. Gender differences in risk factors but not risk. Arterioscler Thromb Vasc Biol 16:720–726
Metadata
Title
Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes
Authors
J. R. Larsen
M. Brekke
L. Bergengen
L. Sandvik
H. Arnesen
K. F. Hanssen
K. Dahl-Jorgensen
Publication date
01-04-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 4/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1700-z

Other articles of this Issue 4/2005

Diabetologia 4/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.